| Non-coding RNAs as regulators in epigenetics JW Wei, K Huang, C Yang, CS Kang Oncology reports 37 (1), 3-9, 2017 | 759 | 2017 |
| Blood exosomes endowed with magnetic and targeting properties for cancer therapy H Qi, C Liu, L Long, Y Ren, S Zhang, X Chang, X Qian, H Jia, J Zhao, ... ACS nano 10 (3), 3323-3333, 2016 | 453 | 2016 |
| Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status X Zhou, Y Ren, L Moore, M Mei, Y You, P Xu, B Wang, G Wang, Z Jia, ... Laboratory investigation 90 (2), 144-155, 2010 | 446 | 2010 |
| MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma CZ Zhang, JX Zhang, AL Zhang, ZD Shi, L Han, ZF Jia, WD Yang, ... Molecular cancer 9, 1-9, 2010 | 400 | 2010 |
| Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding … Q Chen, J Cai, Q Wang, Y Wang, M Liu, J Yang, J Zhou, C Kang, M Li, ... Clinical Cancer Research 24 (3), 684-695, 2018 | 312 | 2018 |
| Clinical practice guidelines for the management of adult diffuse gliomas T Jiang, DH Nam, Z Ram, W Poon, J Wang, D Boldbaatar, Y Mao, W Ma, ... Cancer letters 499, 60-72, 2021 | 289 | 2021 |
| MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol Y Ren, X Zhou, M Mei, XB Yuan, L Han, GX Wang, ZF Jia, P Xu, PY Pu, ... BMC cancer 10, 1-13, 2010 | 272 | 2010 |
| HOTAIR, a cell cycle–associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma JX Zhang, L Han, ZS Bao, YY Wang, LY Chen, W Yan, SZ Yu, PY Pu, ... Neuro-oncology 15 (12), 1595-1603, 2013 | 258 | 2013 |
| Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner K Zhang, X Sun, X Zhou, L Han, L Chen, Z Shi, A Zhang, M Ye, Q Wang, ... Oncotarget 6 (1), 537, 2014 | 255 | 2014 |
| LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis L Han, K Zhang, Z Shi, J Zhang, J Zhu, S Zhu, A Zhang, Z Jia, G Wang, ... International journal of oncology 40 (6), 2004-2012, 2012 | 235 | 2012 |
| Co-delivery of as-miR-21 and 5-FU by poly (amidoamine) dendrimer attenuates human glioma cell growth in vitro Y Ren, CS Kang, XB Yuan, X Zhou, P Xu, L Han, GX Wang, Z Jia, ... Journal of Biomaterials Science, Polymer Edition 21 (3), 303-314, 2010 | 234 | 2010 |
| Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma X Qian, L Long, Z Shi, C Liu, M Qiu, J Sheng, P Pu, X Yuan, Y Ren, ... Biomaterials 35 (7), 2322-2335, 2014 | 205 | 2014 |
| AC1MMYR2, an inhibitor of dicer-mediated biogenesis of oncomir miR-21, reverses epithelial–mesenchymal transition and suppresses tumor growth and progression Z Shi, J Zhang, X Qian, L Han, K Zhang, L Chen, J Liu, Y Ren, M Yang, ... Cancer research 73 (17), 5519-5531, 2013 | 191 | 2013 |
| m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas RC Chai, F Wu, QX Wang, S Zhang, KN Zhang, YQ Liu, Z Zhao, T Jiang, ... Aging (Albany NY) 11 (4), 1204, 2019 | 185 | 2019 |
| DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression X Ning, Z Shi, X Liu, A Zhang, L Han, K Jiang, C Kang, Q Zhang Cancer letters 359 (2), 198-205, 2015 | 182 | 2015 |
| Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells M Mei, Y Ren, X Zhou, X Yuan, L Han, G Wang, Z Jia, P Pu, C Kang, ... Technology in cancer research & treatment 9 (1), 77-86, 2010 | 174 | 2010 |
| Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo C Zhang, C Kang, Y You, P Pu, W Yang, P Zhao, G Wang, A Zhang, Z Jia, ... International journal of oncology 34 (6), 1653-1660, 2009 | 168 | 2009 |
| Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p P Wu, J Cai, Q Chen, B Han, X Meng, Y Li, Z Li, R Wang, L Lin, C Duan, ... Nature communications 10 (1), 2045, 2019 | 164 | 2019 |
| Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme W Yan, W Zhang, L Sun, Y Liu, G You, Y Wang, C Kang, Y You, T Jiang Brain research 1411, 108-115, 2011 | 164 | 2011 |
| Multistage delivery nanoparticle facilitates efficient CRISPR/dCas9 activation and tumor growth suppression in vivo Q Liu, K Zhao, C Wang, Z Zhang, C Zheng, Y Zhao, Y Zheng, C Liu, Y An, ... Advanced Science 6 (1), 1801423, 2019 | 163 | 2019 |